+7 (495) 505-52-05

" "





2013-06-04 20:44:47

. . . , . 250 . 2 . (34), , 500 . 2 . - ? ....
2013-05-15 20:22:14

10. 20. ? ...
2013-05-05 12:39:07

! 4 , , - , ?...
2013-04-24 10:50:26

! : , . : + + . , , , . 2- . - , . . . 3 ......
2013-04-18 21:36:56

! . 50 . . : - , - , . . . - . - , , . , . . ......

,
:

. ""

HEADING_TITLE_2
?
??
20 N14 Cadila Pharmaceuticals
0 1% 15 -
- 10 N28
125 / Laboratoire De La Mer
- 20 N14
125 Laboratoire De La Mer
- 20 N28
125 Laboratoire De La Mer
1 5 N30 -
50 Laboratoire De La Mer
1 5 N60 -
125 Laboratoire De La Mer
35 /
50 Laboratoire De La Mer
2 5+12 5 N100 Actavis Group
0 01% 10
2 5+12 5 N30 Actavis Group
0 025% 10
5+25 N30 Actavis Group
0 05% 10
- 10 N30
10 Zambon S P A
5 /
200
1 N60 Menarini-Von Heyden GmbH
2 N20
500 N60 Menarini-Von Heyden GmbH
2 N20 -
150 N20 PRO MED CS Praha a s
4 N20 -
150 N20
2 N20 Pliva Hrvatska d o o
150 N30
150 N50
100
150 5 N10 / - /
60
&
1 5% 200 - /
10 N30
1 5% 400 - /
20 N30
1 5% 500 - /
3 N10 Famar Lyon
- 3 N5 / - / -
N50
200 N140 -
30
N100
1% 25
N20
10 N30
N30 Teva Pharmaceutical Works Private Co
10 N90
15 N10
20 N30
15 N20
0 75% 30
7 5 N20
10 N28
5% 60 / -
10 N70
15
20 N28
N20 / - /
20 N70
/+/ /- N5
40 N28
7 5/ 20 /
40 N56
N21
10 N30
N213
20 N30
15 /
- 10 N30
30 /
- 10 N60
35 /
- 20 N30
- 625 N30
- 20 N60
- 650 N30
- 20 N90
- 650 N60
- 40 N30
N100 -
- 5 N30
N30 -
10 N30 Zentiva a s
2 N28 -
10 N60 Zentiva a s
2 N28 SmithKline Beecham Pharmaceuticals
10 N90 Zentiva a s
8 N28 SmithKline Beecham Pharmaceuticals
20 N30 Zentiva a s
- 100
20 N60 Zentiva a s
- / 150
40 N30 Zentiva a s
5
10 N28
522 M/L Calse GT
20 N28
( ) 0 55 N20
5 N28
( ) 0 55 N40
/ 45 -
5/ 20 / Glaxo Wellcome Production
/ 45 -
28 4 Sagmel Inc
74 -
N12
/ 74
28 4 Sagmel Inc
74 -
N12
9 (7) -
10 Bayer HealthCare Manufacturing S r L
40 -
N12 Bayer HealthCare Manufacturing S r L
94 -
N12 Sagmel Inc
74 -
40 N2 Pfizer Manufacturing Deutschland
74 -
400 - /
- 74 -
50 N20
74 -
500 N10
74 -
500 N5
74 -
30 N30 Organon
- 74 -
- 10
- 74 -
100 -
74 -
N50 Biologische Heilmittel Heel GmbH
74 -
20 N14
74 -
5 N14

N12
3
N12

N12 /

N24

N24

N24 /

N48

N48 /

/ / 360 Bausch & Lomb
/ 45 -
8 Bausch & Lomb
/ 45 -
/ 120 Bausch & Lomb
/ -- 45 -
/ 240 Bausch & Lomb
/ 45 -
/ 360 Bausch & Lomb
/ 45 -
10% 200 - /
/ 45 -
10% 400 - /
/ / 45 -
7% 5 -
/ 45 -
50
400 -
() 20
/ 400 -
15 N30
/ 400 -
5 N10 / - /
/ 45 -
100 / 10 - []
135 -
100 / 50 - []
135 -
500 N30
60 -
500 N90

200 N50 - - ( )
94 -
2% 10 N10 - /
94 -
2% 5 N10 - /
/ 15 -
0 75 N4 Pierre Fabre Medicament Production
/ 74 -
1% 1 N10 - / -
/ - 74 -
N21
74 -
50 N20
10 N30
50 N20
10 N90
2/ 100 -
15 N30
20 N30
15 N90
N10
20 N30
N4
20 N90
3 N10 /
5 N30
5 N10
5 N90
5 N10
100 - / Biofarm
5 N10
50
5 N5
N20 /
5 N5
25
5 N5
1 N1 / - // + 10 () -
N10
1 N1 / - // + 3 5 () -
5 N10
100 N15
5 N5
100 N6
0 05% 15
10 N14
0 1% 15
10 N7
- 0 05% 20 / Merckle
N20
- 0 1% 20 Merckle
N60
50
50
0 1% 20
/ N100
0 05% 10